Malignant Pleural Mesothelioma
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2009
- Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trialsBritish Journal of Cancer, 2008
- Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesotheliomaBritish Journal of Cancer, 2008
- Systemic Treatments for Mesothelioma: Standard and NovelCurrent Treatment Options in Oncology, 2008
- Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)Lung Cancer, 2008
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialThe Lancet, 2008
- Mesothelin targeted cancer immunotherapyEuropean Journal of Cancer, 2008
- Biomarkers for mesotheliomaCurrent Opinion in Pulmonary Medicine, 2007
- Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with MesotheliomaClinical Cancer Research, 2006
- A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesotheliomaLung Cancer, 2005